{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:19:09Z","timestamp":1791523149662,"version":"4.3.4"},"reference-count":69,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1097\/bor.0b013e3283588dcf","type":"journal-article","created":{"date-parts":[[2012,9,6]],"date-time":"2012-09-06T10:37:11Z","timestamp":1346927831000},"page":"669-676","source":"Crossref","is-referenced-by-count":93,"title":["Renal disease in scleroderma"],"prefix":"10.1097","volume":"24","author":[{"given":"Victoria K.","family":"Shanmugam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia D.","family":"Steen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20210128","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"R2-14-20210128","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis.","volume":"28","author":"LeRoy","year":"2001","journal-title":"J Rheumatol"},{"key":"R3-14-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rdc.2007.12.001","article-title":"The many faces of scleroderma.","volume":"34","author":"Steen","year":"2008","journal-title":"Rheum Dis Clin North Am"},{"key":"R4-14-20210128","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2005.03.005","article-title":"Autoantibodies in systemic sclerosis.","volume":"35","author":"Steen","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"R5-14-20210128","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1445-5994.2010.02281.x","article-title":"Survival in scleroderma: results from the population-based South Australian register.","volume":"41","author":"Hissaria","year":"2011","journal-title":"Intern Med J"},{"key":"R6-14-20210128","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972-2002.","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R7-14-20210128","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0889-857X(03)00016-4","article-title":"Scleroderma renal crisis.","volume":"29","author":"Steen","year":"2003","journal-title":"Rheum Dis Clin North Am"},{"key":"R8-14-20210128","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0002-9343(84)90986-0","article-title":"Factors predicting development of renal involvement in progressive systemic sclerosis.","volume":"76","author":"Steen","year":"1984","journal-title":"Am J Med"},{"key":"R9-14-20210128","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","article-title":"Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.","volume":"66","author":"Walker","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"R10-14-20210128","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3109\/s10165-011-0515-7","article-title":"Clinical features of 405 Japanese patients with systemic sclerosis.","volume":"22","author":"Hashimoto","year":"2012","journal-title":"Mod Rheumatol"},{"key":"R11-14-20210128","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/qjmed\/hcm052","article-title":"Scleroderma renal crisis: patient characteristics and long-term outcomes.","volume":"100","author":"Penn","year":"2007","journal-title":"QJM"},{"key":"R12-14-20210128","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/ard.2006.066985","article-title":"Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients.","volume":"67","author":"Teixeira","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"R13-14-20210128","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1002\/anr.1780320911","article-title":"Normotensive renal failure in systemic sclerosis.","volume":"32","author":"Helfrich","year":"1989","journal-title":"Arthritis Rheum"},{"key":"R14-14-20210128","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/art.1780310311","article-title":"Renal vascular histology and morphometry in systemic sclerosis: a case-control autopsy study.","volume":"31","author":"Trostle","year":"1988","journal-title":"Arthritis Rheum"},{"key":"R15-14-20210128","doi-asserted-by":"crossref","first-page":"881","DOI":"10.7326\/0003-4819-89-6-881","article-title":"The kidney in progressive systemic sclerosis: a prospective study.","volume":"89","author":"Kovalchik","year":"1978","journal-title":"Ann Intern Med"},{"key":"R16-14-20210128","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3899\/jrheum.090677","article-title":"Anti-RNA polymerase iii antibody prevalence and associated clinical manifestations in a large series of French patients with systemic sclerosis: a cross-sectional study.","volume":"37","author":"Meyer","year":"2010","journal-title":"J Rheumatol"},{"key":"R17-14-20210128","doi-asserted-by":"crossref","first-page":"R211","DOI":"10.1186\/ar3544","article-title":"Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort.","volume":"13","author":"Nikpour","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"R18-14-20210128","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1756-185X.2011.01688.x","article-title":"South Australian Scleroderma Register: autoantibodies as predictive biomarkers of phenotype and outcome.","volume":"15","author":"Graf","year":"2012","journal-title":"Int J Rheum Dis"},{"key":"R19-14-20210128","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3109\/03009742.2011.569753","article-title":"Anti-RNA polymerase III antibodies are associated with scleroderma renal crisis in a French cohort.","volume":"40","author":"Emilie","year":"2011","journal-title":"Scand J Rheumatol"},{"key":"R20-14-20210128","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/03009742.2011.610032","article-title":"Scleroderma renal crisis in a Swedish systemic sclerosis cohort: survival, renal outcome, and RNA polymerase III antibodies as a risk factor.","volume":"41","author":"Hesselstrand","year":"2012","journal-title":"Scand J Rheumatol"},{"key":"R21-14-20210128","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1093\/rheumatology\/kep290","article-title":"Clinical usefulness of anti-RNA polymerase III antibody measurement by enzyme-linked immunosorbent assay.","volume":"48","author":"Satoh","year":"2009","journal-title":"Rheumatology"},{"key":"R22-14-20210128","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3899\/jrheum.091048","article-title":"Association of RNA polymerase III antibodies with scleroderma renal crisis.","volume":"37","author":"Nguyen","year":"2010","journal-title":"J Rheumatol"},{"key":"R23-14-20210128","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/art.30111","article-title":"HLA-DRB10407 and 1304 are risk factors for scleroderma renal crisis.","volume":"63","author":"Nguyen","year":"2011","journal-title":"Arthritis Rheum"},{"key":"R24-14-20210128","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/art.24409","article-title":"Anti-U3 RNP autoantibodies in systemic sclerosis.","volume":"60","author":"Aggarwal","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R25-14-20210128","doi-asserted-by":"crossref","first-page":"600","DOI":"10.7326\/0003-4819-133-8-200010170-00010","article-title":"Long-term outcomes of scleroderma renal crisis.","volume":"133","author":"Steen","year":"2000","journal-title":"Ann Intern Med"},{"key":"R26-14-20210128","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.3899\/jrheum.091165","article-title":"Characteristics of Joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) Database.","volume":"37","author":"Avouac","year":"2010","journal-title":"J Rheumatol"},{"key":"R27-14-20210128","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/art.1780400620","article-title":"The palpable tendon friction rub: an important physical examination finding in patients with systemic sclerosis.","volume":"40","author":"Steen","year":"1997","journal-title":"Arthritis Rheum"},{"key":"R28-14-20210128","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1002\/1529-0131(199809)41:9<1613::AID-ART11>3.0.CO;2-O","article-title":"Medsger TA Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis.","volume":"41","author":"Steen","year":"1998","journal-title":"Arthritis Rheum"},{"key":"R29-14-20210128","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/rheumatology\/ker271","article-title":"Scleroderma renal crisis: a retrospective multicentre study on 91 patients and 427 controls.","volume":"51","author":"Guillevin","year":"2012","journal-title":"Rheumatology"},{"key":"R30-14-20210128","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00296-010-1697-6","article-title":"Corticosteroids and the risk of scleroderma renal crisis: a systematic review.","volume":"32","author":"Trang","year":"2012","journal-title":"Rheumatol Int"},{"key":"R31-14-20210128","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1002\/art.22036","article-title":"Endothelin axis polymorphisms in patients with scleroderma.","volume":"54","author":"Fonseca","year":"2006","journal-title":"Arthritis Rheum"},{"key":"R33-14-20210128","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.humpath.2010.05.018","article-title":"Endothelin-1 expression in scleroderma renal crisis.","volume":"42","author":"Mouthon","year":"2011","journal-title":"Hum Pathol"},{"key":"R34-14-20210128","first-page":"1838","article-title":"Circulating endothelin-1 levels in systemic sclerosis subsets: a marker of fibrosis or vascular dysfunction J R","volume":"21","author":"Vancheeswaran","year":"1994","journal-title":"heumatol"},{"key":"R35-14-20210128","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s10067-012-1949-9","article-title":"Increased serum soluble CD147 levels in patients with systemic sclerosis: association with scleroderma renal crisis.","volume":"31","author":"Yanaba","year":"2012","journal-title":"Clin Rheumatol"},{"key":"R36-14-20210128","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3181\/00379727-150-39039","article-title":"Gould AB Serum renin and renin substrate levels in scleroderma.","volume":"50","author":"Fleischmajer","year":"1975","journal-title":"Proc Soc Exp Biol Med"},{"key":"R37-14-20210128","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.semarthrit.2012.01.003","article-title":"Treatment of systemic sclerosis complications: what to use when first-line treatment fails: a consensus of systemic sclerosis experts. Seminars in Arthritis and Rheumatism.","volume":"42","author":"Walker","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"R38-14-20210128","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3899\/jrheum.101262","article-title":"Expert Agreement on EULAREUSTAR recommendations for the management of systemic sclerosis.","volume":"38","author":"Walker","year":"2011","journal-title":"J Rheum"},{"key":"R39-14-20210128","doi-asserted-by":"crossref","first-page":"352","DOI":"10.7326\/0003-4819-113-5-352","article-title":"Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors.","volume":"113","author":"Steen","year":"1990","journal-title":"Ann Intern Med"},{"key":"R40-14-20210128","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/art.1780250301","article-title":"Variable response to oral angiotensin-converting-enzyme blockade in hypertensive scleroderma patients.","volume":"25","author":"Whitman Hr, Case","year":"1982","journal-title":"Arthritis Rheum"},{"key":"R41-14-20210128","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(05)61568-1","article-title":"Failure of losartan to control blood pressure in scleroderma renal crisis.","volume":"349","author":"Caskey","year":"1997","journal-title":"Lancet"},{"key":"R42-14-20210128","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1053\/j.ajkd.2005.01.007","article-title":"Late recurrence of scleroderma renal crisis in a renal transplant recipient despite angiotensin II blockade.","volume":"45","author":"Cheung","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R43-14-20210128","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.ajkd.2009.02.015","article-title":"Endothelin receptor antagonism and renin inhibition as treatment options for scleroderma kidney.","volume":"54","author":"Dhaun","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"R44-14-20210128","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database.","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R45-14-20210128","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1093\/ndt\/gfq861","article-title":"End-stage kidney disease due to scleroderma outcomes in 127 consecutive ANZDATA registry cases.","volume":"26","author":"Siva","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R46-14-20210128","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/j.1525-139X.2010.00769.x","article-title":"Renal function recovery in chronic dialysis patients.","volume":"23","author":"Chu","year":"2010","journal-title":"Semin Dial"},{"key":"R47-14-20210128","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/ndt\/16.6.1163","article-title":"Prognostic value of simple measurement of chronic damage in renal biopsy specimens.","volume":"16","author":"Howie","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"R48-14-20210128","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.humpath.2008.08.001","article-title":"Renal biopsy findings predicting outcome in scleroderma renal crisis.","volume":"40","author":"Batal","year":"2009","journal-title":"Hum Pathol"},{"key":"R49-14-20210128","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1097\/BOR.0b013e3283108df7","article-title":"Diagnosis, management and prevention of scleroderma renal disease.","volume":"20","author":"Penn","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"R50-14-20210128","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1111\/j.1600-6143.2004.00605.x","article-title":"Kidney transplantation for systemic sclerosis improves survival and may modulate disease activity.","volume":"4","author":"Gibney","year":"2004","journal-title":"Am J Transplant"},{"key":"R51-14-20210128","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1111\/j.1600-6143.2005.01035.x","article-title":"Predictors and risk factors for recurrent scleroderma renal crisis in the kidney allograft: case report and review of the literature.","volume":"5","author":"Pham","year":"2005","journal-title":"Am J Transplant"},{"key":"R52-14-20210128","first-page":"e3","article-title":"MPO-ANCA-positive crescentic glomerulonephritis: a distinct entity of scleroderma renal disease Am J Kidney D","volume":"33","author":"Anders","year":"1999","journal-title":"is"},{"key":"R53-14-20210128","doi-asserted-by":"crossref","first-page":"183","DOI":"10.5414\/CNP70183","article-title":"Noncrescentic ANCA-associated renal crisis in systemic sclerosis.","volume":"70","author":"Mimura","year":"2008","journal-title":"Clin Nephrol"},{"key":"R54-14-20210128","first-page":"864","article-title":"Antineutrophil cytoplasmic autoantibodies in 6 patients with renal failure and systemic sclerosis.","volume":"21","author":"Endo","year":"1994","journal-title":"J Rheumatol"},{"key":"R55-14-20210128","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.semarthrit.2010.11.001","article-title":"Anti-neutrophil antibody associated vasculitis in systemic sclerosis.","volume":"41","author":"Arad","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"R56-14-20210128","first-page":"1616","article-title":"Goodpasture-like syndrome induced by D-penicillamine in a patient with systemic sclerosis: report and review of the literature.","volume":"30","author":"Derk","year":"2003","journal-title":"J Rheumatol"},{"key":"R57-14-20210128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-197401000-00001","article-title":"The relationship of hypertension and renal failure in scleroderma (progressive systemic sclerosis) to structural and functional abnormalities of the renal cortical circulation.","volume":"53","author":"Cannon","year":"1974","journal-title":"Medicine (Baltimore)"},{"key":"R58-14-20210128","first-page":"649","article-title":"Kidney disease other than renal crisis in patients with diffuse scleroderma.","volume":"32","author":"Steen","year":"2005","journal-title":"J Rheumatol"},{"key":"R59-14-20210128","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/03009740802629424","article-title":"Renal function is mostly preserved in patients with systemic sclerosis.","volume":"38","author":"Scheja","year":"2009","journal-title":"Scand J Rheumatol"},{"key":"R60-14-20210128","doi-asserted-by":"crossref","first-page":"110","DOI":"10.5414\/CNP70110","article-title":"Intermediate molecular weight proteinuria and albuminuria identify scleroderma patients with increased morbidity.","volume":"70","author":"Seiberlich","year":"2008","journal-title":"Clin Nephrol"},{"key":"R61-14-20210128","first-page":"85","article-title":"The kidney in systemic scleroderma: a report of 38 consecutive cases.","volume":"3","author":"Francois","year":"1982","journal-title":"Nephrologie"},{"key":"R62-14-20210128","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1136\/ard.2011.152892","article-title":"Lack of activation of renal functional reserve predicts the risk of significant renal involvement in systemic sclerosis.","volume":"70","author":"Livi","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R63-14-20210128","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/ard.61.8.682","article-title":"Renal functional reserve is impaired in patients with systemic sclerosis without clinical signs of kidney involvement.","volume":"61","author":"Livi","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"R64-14-20210128","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/rheumatology\/keg023","article-title":"Calculated glomerular filtration rate is a useful screening tool to identify scleroderma patients with renal impairment.","volume":"42","author":"Kingdon","year":"2003","journal-title":"Rheumatology"},{"key":"R65-14-20210128","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1164\/rccm.200912-1820OC","article-title":"Hemodynamic predictors of survival in scleroderma-related pulmonary arterial hypertension.","volume":"182","author":"Campo","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"R66-14-20210128","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10067-010-1389-3","article-title":"Renal disease in systemic sclerosis with normal serum creatinine.","volume":"29","author":"Mohamed","year":"2010","journal-title":"Clin Rheumatol"},{"key":"R67-14-20210128","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/rheumatology\/kes049","article-title":"Evaluation of Chronic Kidney Disease Epidemiology Collaboration equation to estimate glomerular filtration rate in scleroderma patients.","volume":"51","author":"Gigante","year":"2012","journal-title":"Rheumatology"},{"key":"R68-14-20210128","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.semarthrit.2011.11.005","article-title":"Intrarenal hemodynamic parameters correlate with glomerular filtration rate and digital microvascular damage in patients with systemic sclerosis.","volume":"41","author":"Rosato","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"R69-14-20210128","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1038\/aps.2009.128","article-title":"N-acetylcysteine infusion reduces the resistance index of renal artery in the early stage of systemic sclerosis.","volume":"30","author":"Rosato","year":"2009","journal-title":"Acta Pharmacol Sin"},{"key":"R70-14-20210128","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s10067-012-1972-x","article-title":"Increased serum levels of soluble CD163 in patients with scleroderma.","volume":"31","author":"Shimizu","year":"2012","journal-title":"Clin Rheumatol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0b013e3283588dcf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:04:24Z","timestamp":1620947064000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201211000-00014"}},"subtitle":["an update on evaluation, risk stratification, pathogenesis and management"],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":69,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e3283588dcf","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}